SCHEMBL30675621

SCHEMBL30675621

COc1ccc(NC(=O)CSc2nc3cnc(Cl)cc3[nH]2)cc1F

nearest known ligand 0.86

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ENPP1 P22413 19/20 0.86
▸ FPR2 P25090 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20679561 1.00 ENPP1 (0.86) ENPP1FPR2
SCHEMBL20687583 0.92 ENPP1 (0.86) ENPP1FPR2
SCHEMBL20679578 0.88 ENPP1 (0.88) ENPP1FPR2
SCHEMBL30675607 0.88 ENPP1 (0.88) ENPP1FPR2
SCHEMBL20679556 0.88 ENPP1 (0.87) ENPP1FPR2
SCHEMBL30675552 0.88 ENPP1 (0.87) ENPP1FPR2
SCHEMBL30675602 0.88 ENPP1 (0.87) ENPP1FPR2
SCHEMBL20679620 0.88 ENPP1 (0.87) ENPP1FPR2
SCHEMBL20679602 0.87 ENPP1 (0.67) ENPP1FPR2
SCHEMBL21644470 0.87 ENPP1 (0.88) ENPP1FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111615388-B Immunotherapeutic agent for cancer 斯汀格瑞治疗股份有限公司 2023-11-14 — — CN disclosed
Send feedback